Sodium butyrate attenuates liver fibrogenesis via promoting H4K8 crotonylation

Ruiqi Tang1, Hua Zha1, Rongrong Liu2

  • 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou, 310003, China.

Insights

Sodium butyrate (NaB), a histone deacetylase inhibitor, shows promise for treating liver fibrosis. It improves liver function and reduces fibrosis by altering histone crotonylation, offering a novel therapeutic approach.

Area of Science:

  • Biochemistry
  • Hepatology
  • Molecular Biology

Background:

  • Liver fibrosis is a significant health concern.
  • Histone deacetylase (HDAC) inhibitors are being explored for therapeutic potential.
  • Dietary compounds like sodium butyrate (NaB) offer a unique avenue for investigation.

Purpose of the Study:

  • To investigate the therapeutic potential of sodium butyrate (NaB) in liver fibrosis.
  • To elucidate the mechanism of NaB's action through histone crotonylation.
  • To evaluate NaB's effects both in vitro and in vivo.

Main Methods:

  • In vitro studies using TGF-β-stimulated LX2 hepatic stellate cells.
  • In vivo studies using CCl4-induced liver fibrosis model in ICR mice.
  • Analysis of fibrotic markers, HDAC expression, and histone crotonylation (H4K8).

Main Results:

  • NaB inhibited LX2 cell growth and reduced fibrotic markers (ACTA2, COL1A1) dose-dependently.
  • NaB treatment improved liver function and suppressed fibrosis in mice.
  • NaB inhibited Hdac2/Hdac3, increasing H4K8 crotonylation and modulating fibrosis-related genes.

Conclusions:

  • Sodium butyrate (NaB) demonstrates significant efficacy in ameliorating liver fibrosis.
  • NaB's mechanism involves HDAC inhibition and increased histone crotonylation.
  • NaB presents a promising therapeutic strategy for liver disease treatment.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.4K
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
15.0K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.2K